Biotron Limited (ASX:BIT)
Australia · Delayed Price · Currency is AUD 0.0040
+0.0010 (33.33%)
Jan 30, 2026, 2:34 PM AEST
Biotron Market Cap
Biotron has a market cap or net worth of 7.23 million as of January 30, 2026. Its market cap has decreased by -55.50% in one year.
Market Cap
7.23M
Enterprise Value
6.30M
Revenue
1.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since March 19, 2001, Biotron's market cap has decreased from 12.40M to 7.23M, a decrease of -41.71%. That is a compound annual growth rate of -2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 9.64M | 33.33% |
| Dec 31, 2025 | 7.23M | -55.50% |
| Dec 31, 2024 | 16.24M | -81.44% |
| Dec 29, 2023 | 87.52M | 259.40% |
| Dec 30, 2022 | 24.35M | -64.23% |
| Dec 31, 2021 | 68.09M | 24.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tissue Repair | 18.44M |
| Immuron | 12.69M |
| AdAlta | 11.48M |
| Chimeric Therapeutics | 11.05M |
| Patrys | 10.22M |
| Bio-Gene Technology | 9.46M |
| Invex Therapeutics | 9.02M |
| Zelira Therapeutics | 8.09M |